rs10407144

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001127222.2(CACNA1A):​c.1346-3430A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.2 in 152,086 control chromosomes in the GnomAD database, including 3,117 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 3117 hom., cov: 31)

Consequence

CACNA1A
NM_001127222.2 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.76

Publications

5 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001127222.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.27 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127222.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1A
NM_001127222.2
MANE Select
c.1346-3430A>G
intron
N/ANP_001120694.1O00555-8
CACNA1A
NM_001127221.2
MANE Plus Clinical
c.1349-3430A>G
intron
N/ANP_001120693.1O00555-3
CACNA1A
NM_023035.3
c.1349-3430A>G
intron
N/ANP_075461.2A0A087WW63

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1A
ENST00000360228.11
TSL:1 MANE Select
c.1346-3430A>G
intron
N/AENSP00000353362.5O00555-8
CACNA1A
ENST00000638009.2
TSL:1 MANE Plus Clinical
c.1349-3430A>G
intron
N/AENSP00000489913.1O00555-3
CACNA1A
ENST00000638029.1
TSL:5
c.1349-3430A>G
intron
N/AENSP00000489829.1A0A087WW63

Frequencies

GnomAD3 genomes
AF:
0.200
AC:
30447
AN:
151968
Hom.:
3112
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.208
Gnomad AMI
AF:
0.0934
Gnomad AMR
AF:
0.187
Gnomad ASJ
AF:
0.192
Gnomad EAS
AF:
0.283
Gnomad SAS
AF:
0.205
Gnomad FIN
AF:
0.182
Gnomad MID
AF:
0.272
Gnomad NFE
AF:
0.196
Gnomad OTH
AF:
0.211
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.200
AC:
30468
AN:
152086
Hom.:
3117
Cov.:
31
AF XY:
0.199
AC XY:
14812
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.208
AC:
8627
AN:
41474
American (AMR)
AF:
0.187
AC:
2854
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.192
AC:
666
AN:
3470
East Asian (EAS)
AF:
0.282
AC:
1456
AN:
5160
South Asian (SAS)
AF:
0.204
AC:
984
AN:
4812
European-Finnish (FIN)
AF:
0.182
AC:
1923
AN:
10580
Middle Eastern (MID)
AF:
0.279
AC:
82
AN:
294
European-Non Finnish (NFE)
AF:
0.196
AC:
13348
AN:
67988
Other (OTH)
AF:
0.210
AC:
443
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1222
2444
3666
4888
6110
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
344
688
1032
1376
1720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.198
Hom.:
12726
Bravo
AF:
0.202
Asia WGS
AF:
0.228
AC:
796
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
8.4
DANN
Benign
0.62
PhyloP100
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10407144;
hg19: chr19-13431565;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.